FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970036264> ?p ?o ?g. }

• W1970036264 endingPage "2081" @default.
• W1970036264 startingPage "2074" @default.
• W1970036264 abstract "To determine whether 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) affect the risk of developing open-angle glaucoma (OAG) in persons with hyperlipidemia.Retrospective, longitudinal cohort analysis.Individuals aged ≥60 years with hyperlipidemia enrolled in a national United States managed care network between 2001 and 2009.Multivariable Cox regression analyses were performed to assess the relationship between statin use and the development of OAG (from no prior OAG diagnosis), progression from a prior diagnosis of glaucoma suspect to a diagnosis of OAG, and need for medical or operative interventions for OAG. Regression models were adjusted for sociodemographic factors and medical and ocular comorbidities.Hazard ratios (HRs) with 95% confidence intervals (CIs).Of the 524 109 individuals with hyperlipidemia, 316 182 (60%) had ≥1 outpatient prescription for statins. The hazard of developing OAG decreased 0.3% (adjusted HR, 0.997; 95% CI 0.994-0.999) for every additional month of statin consumption. Individuals with hyperlipidemia who took statins continuously for 2 years had an 8% (adjusted HR, 0.922; 95% CI, 0.870-0.976) decreased OAG risk relative to those who received no statin therapy. The hazard of progressing from a diagnosis of glaucoma suspect to OAG decreased 0.4% (adjusted HR, 0.996; 95% CI, 0.993-0.999) for every additional month of statin exposure. Individuals who took statins continuously for 2 years had a 9% (adjusted HR, 0.907; 95% CI, 0.846-0.973) decreased risk of progressing from glaucoma suspect to OAG relative to those who received no statin therapy. The hazard of requiring medical treatment for OAG decreased 0.4% (adjusted HR, 0.996; 95% CI, 0.993-0.998) for every additional month of statin exposure. No differences in need for glaucoma surgery were noted among those with OAG who were and were not taking statins (adjusted HR, 1.002; 95% CI, 0.994-1.010).Statin use was associated with a significant reduction in the risk of OAG among persons with hyperlipidemia. Given the mounting evidence of statin protection against OAG including both basic science and observational clinical studies, an interventional prospective study might provide additional insights into the role of statins in the prevention of early OAG." @default.
• W1970036264 created "2016-06-24" @default.
• W1970036264 creator A5009800657 @default.
• W1970036264 creator A5042341272 @default.
• W1970036264 creator A5055521200 @default.
• W1970036264 creator A5058262329 @default.
• W1970036264 creator A5062252450 @default.
• W1970036264 creator A5085528800 @default.
• W1970036264 date "2012-10-01" @default.
• W1970036264 modified "2023-10-11" @default.
• W1970036264 title "The Relationship Between Statin Use and Open-Angle Glaucoma" @default.
• W1970036264 cites W1492482999 @default.
• W1970036264 cites W1495370737 @default.
• W1970036264 cites W184629237 @default.
• W1970036264 cites W1967076538 @default.
• W1970036264 cites W1973235785 @default.
• W1970036264 cites W1980448847 @default.
• W1970036264 cites W1995801522 @default.
• W1970036264 cites W2000024028 @default.
• W1970036264 cites W2000445173 @default.
• W1970036264 cites W2018071295 @default.
• W1970036264 cites W2020175163 @default.
• W1970036264 cites W2021519220 @default.
• W1970036264 cites W2021883141 @default.
• W1970036264 cites W2021953612 @default.
• W1970036264 cites W2031050247 @default.
• W1970036264 cites W2033873037 @default.
• W1970036264 cites W2050561275 @default.
• W1970036264 cites W2063120410 @default.
• W1970036264 cites W2065510468 @default.
• W1970036264 cites W2072087952 @default.
• W1970036264 cites W2081862621 @default.
• W1970036264 cites W2111034954 @default.
• W1970036264 cites W2115619413 @default.
• W1970036264 cites W2119021779 @default.
• W1970036264 cites W2124033302 @default.
• W1970036264 cites W2129750583 @default.
• W1970036264 cites W2136622296 @default.
• W1970036264 cites W2151744853 @default.
• W1970036264 cites W2163425016 @default.
• W1970036264 cites W2411098478 @default.
• W1970036264 doi "https://doi.org/10.1016/j.ophtha.2012.04.029" @default.
• W1970036264 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3459293" @default.
• W1970036264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22727176" @default.
• W1970036264 hasPublicationYear "2012" @default.
• W1970036264 type Work @default.
• W1970036264 sameAs 1970036264 @default.
• W1970036264 citedByCount "87" @default.
• W1970036264 countsByYear W19700362642013 @default.
• W1970036264 countsByYear W19700362642014 @default.
• W1970036264 countsByYear W19700362642015 @default.
• W1970036264 countsByYear W19700362642016 @default.
• W1970036264 countsByYear W19700362642017 @default.
• W1970036264 countsByYear W19700362642018 @default.
• W1970036264 countsByYear W19700362642019 @default.
• W1970036264 countsByYear W19700362642020 @default.
• W1970036264 countsByYear W19700362642021 @default.
• W1970036264 countsByYear W19700362642022 @default.
• W1970036264 countsByYear W19700362642023 @default.
• W1970036264 crossrefType "journal-article" @default.
• W1970036264 hasAuthorship W1970036264A5009800657 @default.
• W1970036264 hasAuthorship W1970036264A5042341272 @default.
• W1970036264 hasAuthorship W1970036264A5055521200 @default.
• W1970036264 hasAuthorship W1970036264A5058262329 @default.
• W1970036264 hasAuthorship W1970036264A5062252450 @default.
• W1970036264 hasAuthorship W1970036264A5085528800 @default.
• W1970036264 hasBestOaLocation W19700362641 @default.
• W1970036264 hasConcept C118487528 @default.
• W1970036264 hasConcept C126322002 @default.
• W1970036264 hasConcept C134018914 @default.
• W1970036264 hasConcept C207103383 @default.
• W1970036264 hasConcept C2776839432 @default.
• W1970036264 hasConcept C2778527774 @default.
• W1970036264 hasConcept C2779091943 @default.
• W1970036264 hasConcept C2991803831 @default.
• W1970036264 hasConcept C44249647 @default.
• W1970036264 hasConcept C50382708 @default.
• W1970036264 hasConcept C555293320 @default.
• W1970036264 hasConcept C71924100 @default.
• W1970036264 hasConceptScore W1970036264C118487528 @default.
• W1970036264 hasConceptScore W1970036264C126322002 @default.
• W1970036264 hasConceptScore W1970036264C134018914 @default.
• W1970036264 hasConceptScore W1970036264C207103383 @default.
• W1970036264 hasConceptScore W1970036264C2776839432 @default.
• W1970036264 hasConceptScore W1970036264C2778527774 @default.
• W1970036264 hasConceptScore W1970036264C2779091943 @default.
• W1970036264 hasConceptScore W1970036264C2991803831 @default.
• W1970036264 hasConceptScore W1970036264C44249647 @default.
• W1970036264 hasConceptScore W1970036264C50382708 @default.
• W1970036264 hasConceptScore W1970036264C555293320 @default.
• W1970036264 hasConceptScore W1970036264C71924100 @default.
• W1970036264 hasIssue "10" @default.
• W1970036264 hasLocation W19700362641 @default.
• W1970036264 hasLocation W19700362642 @default.
• W1970036264 hasLocation W19700362643 @default.
• W1970036264 hasLocation W19700362644 @default.
• W1970036264 hasOpenAccess W1970036264 @default.
• W1970036264 hasPrimaryLocation W19700362641 @default.

• next